Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA GSK PHARMA AUROBINDO PHARMA/
GSK PHARMA
 
P/E (TTM) x 12.8 57.5 22.3% View Chart
P/BV x 1.1 8.5 13.0% View Chart
Dividend Yield % 1.9 6.7 28.7%  

Financials

 AUROBINDO PHARMA   GSK PHARMA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-22
GSK PHARMA
Mar-22
AUROBINDO PHARMA/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0641,917 55.5%   
Low Rs5841,400 41.7%   
Sales per share (Unadj.) Rs400.3193.5 206.9%  
Earnings per share (Unadj.) Rs45.722.5 203.4%  
Cash flow per share (Unadj.) Rs64.926.5 245.0%  
Dividends per share (Unadj.) Rs9.0090.00 10.0%  
Avg Dividend yield %1.15.4 20.1%  
Book value per share (Unadj.) Rs419.4157.2 266.8%  
Shares outstanding (eoy) m585.94169.41 345.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.18.6 24.0%   
Avg P/E ratio x18.073.8 24.4%  
P/CF ratio (eoy) x12.762.6 20.3%  
Price / Book Value ratio x2.010.6 18.6%  
Dividend payout %19.7400.4 4.9%   
Avg Mkt Cap Rs m482,799280,960 171.8%   
No. of employees `000NANA-   
Total wages/salary Rs m34,5096,102 565.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m234,55532,780 715.5%  
Other income Rs m3,226758 425.7%   
Total revenues Rs m237,78133,538 709.0%   
Gross profit Rs m42,5667,735 550.3%  
Depreciation Rs m11,265682 1,652.1%   
Interest Rs m48620 2,436.9%   
Profit before tax Rs m34,0407,790 436.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2563,983 182.2%   
Profit after tax Rs m26,7843,808 703.4%  
Gross profit margin %18.123.6 76.9%  
Effective tax rate %21.351.1 41.7%   
Net profit margin %11.411.6 98.3%  
BALANCE SHEET DATA
Current assets Rs m181,22737,080 488.7%   
Current liabilities Rs m81,56016,984 480.2%   
Net working cap to sales %42.561.3 69.3%  
Current ratio x2.22.2 101.8%  
Inventory Days Days2591 27.5%  
Debtors Days Days62229 27.3%  
Net fixed assets Rs m155,1048,121 1,909.9%   
Share capital Rs m5861,694 34.6%   
"Free" reserves Rs m245,17424,936 983.2%   
Net worth Rs m245,76026,630 922.9%   
Long term debt Rs m2,4920-   
Total assets Rs m336,33145,201 744.1%  
Interest coverage x71.0391.3 18.1%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.7 96.2%   
Return on assets %8.18.5 95.7%  
Return on equity %10.914.3 76.2%  
Return on capital %13.929.3 47.4%  
Exports to sales %31.10-   
Imports to sales %11.927.0 44.1%   
Exports (fob) Rs m72,862NA-   
Imports (cif) Rs m27,9658,853 315.9%   
Fx inflow Rs m77,245528 14,635.9%   
Fx outflow Rs m31,5248,853 356.1%   
Net fx Rs m45,721-8,325 -549.2%   
CASH FLOW
From Operations Rs m50,1658,107 618.7%  
From Investments Rs m-32,116-4,055 792.0%  
From Financial Activity Rs m-29,693-5,242 566.4%  
Net Cashflow Rs m-11,674-1,190 981.0%  

Share Holding

Indian Promoters % 48.8 0.0 -  
Foreign collaborators % 3.1 75.0 4.1%  
Indian inst/Mut Fund % 38.0 12.7 298.7%  
FIIs % 21.4 2.2 986.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 25.0 192.7%  
Shareholders   358,459 116,651 307.3%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    ZYDUS LIFESCIENCES    


More on Aurobindo Pharma vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs GSK Pharma Share Price Performance

Period Aurobindo Pharma GSK Pharma S&P BSE HEALTHCARE
1-Day 1.78% 2.59% 0.33%
1-Month -10.75% -2.10% 0.28%
1-Year -30.62% -24.19% -6.55%
3-Year CAGR 1.78% -7.04% 20.31%
5-Year CAGR -8.38% -11.68% 10.96%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 9.0 per share. This amounted to a Dividend Payout ratio of 19.7%.

GSK Pharma paid Rs 90.0, and its dividend payout ratio stood at 400.4%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of GSK Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 21 Points Higher | BHEL, RVNL Surge 10% to Hit 52-Week High | Why PNB Share Price is Rising(Closing)

Indian share markets traded in a rangebound manner throughout today's session to end flat.